Management of the Failed Transurethral Resection of the Prostate

[1]  C. Roehrborn,et al.  Evaluation and treatment of lower urinary tract symptoms in older men. , 2009, The Journal of urology.

[2]  J. Nickel,et al.  Impact of medical therapy on transurethral resection of the prostate: two decades of change , 2011, BJU international.

[3]  K. Matzel,et al.  How does neuromodulation work , 2011, Neurourology and urodynamics.

[4]  John T. Wei,et al.  Update on AUA guideline on the management of benign prostatic hyperplasia. , 2011, The Journal of urology.

[5]  X. Gamé,et al.  Neuromodulation sacrée avec le système InterStim™ : résultats du registre national français , 2011 .

[6]  D. Georgescu,et al.  TURP for BPH. How Large is Too Large? , 2010, Journal of medicine and life.

[7]  F. Montorsi,et al.  Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. , 2010, European urology.

[8]  J. Boura,et al.  Chronic pudendal neuromodulation: Expanding available treatment options for refractory urologic symptoms , 2010, Neurourology and urodynamics.

[9]  R. Hoekstra,et al.  A 10‐year follow‐up after transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia; long‐term results of a randomized controlled trial , 2010, BJU international.

[10]  E. Rovner,et al.  Urodynamics in the Evaluation of Overactive Bladder , 2010, Current urology reports.

[11]  V. Nitti,et al.  Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity , 2010, BJU international.

[12]  S. de Wachter,et al.  Current Information on Sacral Neuromodulation and Botulinum Toxin Treatment for Refractory Idiopathic Overactive Bladder Syndrome: A Review , 2010, Urologia Internationalis.

[13]  N. Masumori,et al.  The 12‐year symptomatic outcome of transurethral resection of the prostate for patients with lower urinary tract symptoms suggestive of benign prostatic obstruction compared to the urodynamic findings before surgery , 2009, BJU international.

[14]  Daniela M. Darrah,et al.  Postoperative urinary retention. , 2009, Anesthesiology clinics.

[15]  S. Shobeiri,et al.  Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. , 2009, The Journal of urology.

[16]  S. Naito,et al.  Analysis of the prognostic factors for overactive bladder symptoms following surgical treatment in patients with benign prostatic obstruction , 2009, Neurourology and urodynamics.

[17]  M. Drake.  Mechanisms of action of intravesical botulinum treatment in refractory detrusor overactivity , 2008, BJU international.

[18]  Alexander Bachmann,et al.  Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. , 2008, The Journal of urology.

[19]  John T. Wei,et al.  Refractory idiopathic urge urinary incontinence and botulinum A injection. , 2008, The Journal of urology.

[20]  M. Fall,et al.  Urodynamic evaluation of sacral neuromodulation for urge urinary incontinence , 2008, BJU international.

[21]  F. Klein,et al.  Sacral nerve stimulation for treatment of refractory urinary retention: long-term efficacy and durability. , 2007, Urology.

[22]  P. Dasgupta,et al.  Urodynamic assessment of poor responders after botulinum toxin-A treatment for overactive bladder. , 2008, Urology.

[23]  M. Elhilali,et al.  Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. , 2007, The Journal of urology.

[24]  P. Dasgupta,et al.  Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial. , 2007, The Journal of urology.

[25]  G. Bartsch,et al.  Persistent detrusor overactivity after transurethral resection of the prostate is associated with reduced perfusion of the urinary bladder , 2007 .

[26]  G. Webster,et al.  Detrusor overactivity does not predict outcome of sacral neuromodulation test stimulation , 2007, International Urogynecology Journal.

[27]  Rainer Hofmann,et al.  Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention. , 2006, European urology.

[28]  N. Masumori,et al.  Is the short‐term outcome of transurethral resection of the prostate affected by preoperative degree of bladder outlet obstruction, status of detrusor contractility or detrusor overactivity? , 2006, International journal of urology : official journal of the Japanese Urological Association.

[29]  K. Andersson,et al.  Antimuscarinic drugs in detrusor overactivity and the overactive bladder syndrome: motor or sensory actions? , 2006, BJU international.

[30]  P. Abrams,et al.  The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic followup of transurethral resection of prostate for bladder outlet obstruction. , 2005, The Journal of urology.

[31]  J. Bosch,et al.  Chronic pudendal nerve neuromodulation in women with idiopathic refractory detrusor overactivity incontinence: Results of a pilot study with a novel minimally invasive implantable mini‐stimulator , 2005, Neurourology and urodynamics.

[32]  J. Blaivas,et al.  Long-term followup of augmentation enterocystoplasty and continent diversion in patients with benign disease. , 2005, The Journal of urology.

[33]  Mark Emberton,et al.  EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). , 2004, European urology.

[34]  E. Erdem,et al.  Can the outcome of transurethral resection of the prostate be predicted preoperatively? , 2004, Urology.

[35]  P. Abrams,et al.  The natural history of lower urinary tract dysfunction in men: the influence of detrusor underactivity on the outcome after transurethral resection of the prostate with a minimum 10‐year urodynamic follow‐up , 2004, BJU international.

[36]  R. Hindley,et al.  Prostaglandin E2 and bethanechol in combination for treating detrusor underactivity , 2004, BJU international.

[37]  A. Brading,et al.  Effects of metabolic stress and ischaemia on the bladder, and the relationship with bladder overactivity , 2004, Scandinavian journal of urology and nephrology. Supplementum.

[38]  P. Abrams,et al.  Describing bladder storage function: overactive bladder syndrome and detrusor overactivity. , 2003, Urology.

[39]  O. Yossepowitch,et al.  Detrusor resistive index evaluated by Doppler ultrasonography as a potential indicator of bladder outlet obstruction. , 2003, Urology.

[40]  C. Pinnock,et al.  Preoperative urodynamic and symptom evaluation of patients undergoing transurethral prostatectomy: analysis of variables relevant for outcome , 2003, BJU international.

[41]  C. De Nunzio,et al.  The evolution of detrusor overactivity after watchful waiting, medical therapy and surgery in patients with bladder outlet obstruction. , 2003, The Journal of urology.

[42]  H. V. van Melick,et al.  Correlations of urodynamic changes with changes in symptoms and well-being after transurethral resection of the prostate. , 2002, The Journal of urology.

[43]  D. Porru,et al.  Prognostic value of a combination of IPSS, flow rate and residual urine volume compared to pressure-flow studies in the preoperative evaluation of symptomatic BPH. , 2002, European urology.

[44]  M. Elhilali,et al.  Efficacy of sacral nerve stimulation for urinary retention: results 18 months after implantation. , 2001, The Journal of urology.

[45]  R. Dmochowski,et al.  Effect of bladder management on urological complications in spinal cord injured patients. , 2000, The Journal of urology.

[46]  S. Kageyama,et al.  Can persisting detrusor hyperreflexia be predicted after transurethral prostatectomy for benign prostatic hypertrophy? , 2000, Neurourology and urodynamics.

[47]  Marberger,et al.  Is transurethral resection of the prostate still justified? , 1999, BJU international.

[48]  P. Javlé,et al.  Grading of benign prostatic obstruction can predict the outcome of transurethral prostatectomy. , 1998, The Journal of urology.

[49]  D. Ilstrup,et al.  Urinary retention after operations for benign anorectal diseases , 1998, Diseases of the colon and rectum.

[50]  C. Fowler,et al.  The neurophysiology of urinary retention in young women and its treatment by neuromodulation , 1998, World Journal of Urology.

[51]  M. Marberger,et al.  Urodynamic assessment of patients with acute urinary retention: is treatment failure after prostatectomy predictable? , 1997, The Journal of urology.

[52]  H. Klingler,et al.  Is obstruction predictable by clinical evaluation in patients with lower urinary tract symptoms? , 1997, British journal of urology.

[53]  D. Griffiths,et al.  Effect of transurethral resection of the prostate on detrusor instability and urge incontinence in elderly males , 1993, Neurourology and urodynamics.

[54]  A. Finkbeiner.  Is bethanechol chloride clinically effective in promoting bladder emptying? A literature review. , 1985, The Journal of urology.

[55]  D J Farrar,et al.  The results of prostatectomy: a symptomatic and urodynamic analysis of 152 patients. , 1979, The Journal of urology.